G1 Therapeutics Stock (NASDAQ: GTHX) stock price, news, charts, stock research, profile.
Open | $2.53 |
Close | $2.57 |
Volume / Avg. | 852.76K / 1.52M |
Day Range | 2.50 - 2.73 |
52 Wk Range | 1.08 - 6.14 |
Market Cap | $134.89M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 9.45% |
Days to Cover | 7.24 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of G1 Therapeutics (NASDAQ:GTHX) through any online brokerage.
Other companies in G1 Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), Atossa Therapeutics (NASDAQ:ATOS) and Tevogen Bio Holdings (NASDAQ:TVGN).
There is no analysis for G1 Therapeutics.
G1 Therapeutics has a consensus price target of $13.71.
The stock price for G1 Therapeutics (NASDAQ: GTHX) is $2.58 last updated Today at July 8, 2024 at 4:43 PM EDT.
There are no upcoming dividends for G1 Therapeutics.
G1 Therapeutics’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
There is no upcoming split for G1 Therapeutics.
G1 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.